Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
China · Delayed Price · Currency is CNY 16.64
+0.01 (0.06%)
Feb 3, 2026, 3:04 PM CST
SHE:002020 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 712.56 | 711.96 | 618.9 | 662.25 | 612.54 | 653.07 |
Depreciation & Amortization | 288.66 | 288.66 | 219.95 | 166.87 | 149.92 | 123.2 |
Other Amortization | 22.11 | 22.11 | 11.55 | 33.08 | 32.6 | 31.22 |
Loss (Gain) From Sale of Assets | -2.59 | -2.59 | -6.86 | -0.61 | 0.48 | 0.04 |
Asset Writedown & Restructuring Costs | 0.07 | 0.07 | 0.01 | 0.07 | 8.42 | 0.51 |
Loss (Gain) From Sale of Investments | 33.41 | 33.41 | -30.88 | -29.57 | -55.39 | -191.15 |
Provision & Write-off of Bad Debts | 13.16 | 13.16 | 6.73 | 3.64 | 10.8 | -1.81 |
Other Operating Activities | 28.39 | 26.2 | 15.63 | -1.3 | 22.77 | 19.09 |
Change in Accounts Receivable | -249.65 | -249.65 | -93.48 | -250.89 | -208.58 | 34.44 |
Change in Inventory | -152.84 | -152.84 | 123.04 | -102.95 | -152.51 | -82.69 |
Change in Accounts Payable | 52.3 | 52.3 | -74.58 | 387.41 | -41.84 | -103.68 |
Change in Other Net Operating Assets | - | - | - | - | - | -0.03 |
Operating Cash Flow | 728.95 | 726.16 | 792.84 | 855.78 | 373.46 | 513.21 |
Operating Cash Flow Growth | -19.46% | -8.41% | -7.36% | 129.15% | -27.23% | -4.13% |
Capital Expenditures | -227.37 | -250.65 | -519.51 | -515.57 | -406.83 | -334 |
Sale of Property, Plant & Equipment | 4.2 | 5.2 | 10.27 | 1.99 | 2.93 | 2.44 |
Investment in Securities | 767.06 | -1,240 | -260.2 | -342.4 | 508.33 | 707.69 |
Other Investing Activities | 60.96 | 47.86 | 31.85 | 118.32 | 37.86 | 87.8 |
Investing Cash Flow | 604.85 | -1,438 | -737.59 | -737.66 | 142.29 | 463.93 |
Long-Term Debt Issued | - | 738.29 | 585 | 236.54 | 146.16 | 297.6 |
Total Debt Issued | 541.9 | 738.29 | 585 | 236.54 | 146.16 | 297.6 |
Long-Term Debt Repaid | - | -757.56 | -568.33 | -166.05 | -320.64 | -358.76 |
Total Debt Repaid | -747.56 | -757.56 | -568.33 | -166.05 | -320.64 | -358.76 |
Net Debt Issued (Repaid) | -205.66 | -19.27 | 16.67 | 70.49 | -174.48 | -61.15 |
Issuance of Common Stock | - | - | - | - | 515.56 | - |
Repurchase of Common Stock | - | - | - | - | - | -200.99 |
Common Dividends Paid | -284.85 | -258.31 | -258.31 | -258.56 | -232.17 | -235.42 |
Other Financing Activities | -615.15 | -2.58 | -3.97 | 0.04 | 4.47 | 0.18 |
Financing Cash Flow | -1,106 | -280.16 | -245.61 | -188.03 | 113.38 | -497.38 |
Foreign Exchange Rate Adjustments | 1.3 | 2.99 | 2.71 | 14.87 | -3.75 | -9.95 |
Net Cash Flow | 229.44 | -988.87 | -187.65 | -55.05 | 625.38 | 469.81 |
Free Cash Flow | 501.59 | 475.52 | 273.32 | 340.2 | -33.37 | 179.21 |
Free Cash Flow Growth | -22.45% | 73.98% | -19.66% | - | - | -9.47% |
Free Cash Flow Margin | 12.55% | 11.43% | 6.83% | 9.00% | -0.96% | 5.50% |
Free Cash Flow Per Share | 0.60 | 0.55 | 0.32 | 0.40 | -0.04 | 0.23 |
Cash Income Tax Paid | 293.02 | 260.88 | 245.5 | 262.09 | 231.14 | 246.5 |
Levered Free Cash Flow | -456.03 | 539.05 | -85.08 | 312.3 | -204.19 | -31.16 |
Unlevered Free Cash Flow | -452.58 | 543.89 | -80.51 | 316.06 | -201.08 | -27.41 |
Change in Working Capital | -366.83 | -366.83 | -42.18 | 21.35 | -408.69 | -120.95 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.